| 000 | 01082 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250516033440.0 | ||
| 264 | 0 | _c20110829 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1179-2027 | ||
| 024 | 7 |
_a10.2165/11589240-000000000-00000 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAnonychuk, Andrea | |
| 245 | 0 | 0 |
_aHealth economic and infectious disease modelling: a guide to merging streams. _h[electronic resource] |
| 260 |
_bPharmacoEconomics _cMay 2011 |
||
| 300 |
_a367-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aCommunicable Disease Control _xeconomics |
| 650 | 0 | 4 |
_aCommunicable Diseases _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aEconomics, Medical |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMarkov Chains |
| 650 | 0 | 4 | _aModels, Economic |
| 700 | 1 | _aKrahn, Murray | |
| 773 | 0 |
_tPharmacoEconomics _gvol. 29 _gno. 5 _gp. 367-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/11589240-000000000-00000 _zAvailable from publisher's website |
| 999 |
_c20769936 _d20769936 |
||